Review
Accepted on 17 Oct 2024
The possibility of off-label uses of β-blockers and statins in the breast, colorectal, prostate and lung cancers: an update
in Experimental Pharmacology and Drug Discovery
Review
Accepted on 17 Oct 2024
in Experimental Pharmacology and Drug Discovery
Original Research
Accepted on 17 Oct 2024
in Breast Cancer
Brief Research Report
Accepted on 17 Oct 2024
in Neuropharmacology
Systematic Review
Published on 17 Oct 2024
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Original Research
Published on 17 Oct 2024
in Functional Plant Ecology
Original Research
Published on 17 Oct 2024
in Plant Nutrition
Original Research
Published on 17 Oct 2024
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Published on 17 Oct 2024
in Networks of Dynamical Systems
Systematic Review
Published on 17 Oct 2024
in Infectious Diseases: Epidemiology and Prevention
Review
Published on 17 Oct 2024
in Gastroenterology
Original Research
Published on 17 Oct 2024
in Hematologic Malignancies
Original Research
Published on 17 Oct 2024
in Psychology for Clinical Settings
Original Research
Published on 17 Oct 2024
in Genome Organization and Dynamics
Original Research
Published on 17 Oct 2024
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Original Research
Published on 17 Oct 2024
in Aging and Public Health
Original Research
Published on 17 Oct 2024
in Human-Wildlife Interactions